KNK437, a benzylidene lactam compound, sensitises prostate cancer cells to the apoptotic effect of hyperthermia
/in Hyperthermia, International Publications, Prostate Cancer[Study on the specific immunity induced by dendritic cell vaccine loading allogenic microvascular endothelial cell bEnd.3 antigen against U14 cervical cancer cell in mice]
/in Cervical Cancer, Dendritic Cells, International PublicationsNew perspectives in glioma immunotherapy
/in Dendritic Cells, Glioblastoma, International PublicationsInhibition of B16 murine melanoma metastasis and enhancement of immunity by fever-range whole body hyperthermia
/in Hyperthermia, International PublicationsSipuleucel-T: in metastatic castration-resistant prostate cancer
/in Dendritic Cells, International Publications, Prostate CancerInduction of cellular immune responses in patients with stage-I multiple myeloma after vaccination with autologous idiotype-pulsed dendritic cells
/in Dendritic Cells, International Publications, Multiple MyelomaImmunotherapy as a strategy for the treatment of non-small-cell lung cancer
/in International Publications, NSCLCGene carriers and transfection systems used in the recombination of dendritic cells for effective cancer immunotherapy
/in Dendritic Cells, International PublicationsAntitumor vaccination by Newcastle Disease Virus Hemagglutinin-Neuraminidase plasmid DNA application: changes in tumor microenvironment and activation of innate anti-tumor immunity
/in International Publications, IOZK Veröffentlichungen, Newcastle Disease VirusIMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer